Affordable Medical Equipment :: Diabetes Articles :: Amlyn AMLN : Gila Monster Saliva Leads to Once-a-Week Diabetes Insulin Injection
|
|
|
Amlyn AMLN : Gila Monster Saliva Leads to Once-a-Week Diabetes Insulin Injection
AMYLIN is developing Exenatide which is now in phase 3 development and should roll out by the end of this year upon FDA approval.
A synthetic derivative of enzymes found in Gila Monster saliva are the foundation of this product which allows for medication weekly instead of daily.
Current use requires two injections in the stomach once per week which will be a huge benefit to Type I diabetes sufferers around the world.
MedAME will stay on top of this drugs development and update this article as news comes in.
Related Products
Minimed MMT380 23 Inch Combo Silhouette (10 Sites/5 Tubing Sets) 10/Box
The comfort of an angled insertion with the convenience of disconnecting at the infusion site. All in a discrete, low-profile design. This model comes...
Prestige Test Strips 50/Box
Test Strips Uses With flip top vial. For whole blood glucose testing using products that feature the Prestige Smart System logo. For use with ...
BD Pen Needle Original 29 Gauge 1/2inch 100/box
(Last 4 digits of Product code are 8203) The BD Ultra-FineT Original Pen Needle is 29 gauge 12.7 mm (1/2""). It's identical to the needle on the BD Ul...
Read the next Diabetes article on Diabetes & Diabetic Government & Industry Website Links